½ÃÀ庸°í¼­
»óǰÄÚµå
1193069

¿ø°ÝÁ¤½Å°ú ½ÃÀå : Á¦Ç° À¯Çüº°, ¿¬·ÉÃþº°, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ±âȸ ºÐ¼® ¹× »ê¾÷ ¿¹Ãø(2021-2031³â)

Telepsychiatry Market By Product Type, By Age group, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Allied Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 290 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¿ø°ÝÁ¤½Å°ú ½ÃÀåÀº 2021³â¿¡ 65¾ï 3100¸¸ ´Þ·¯, 2031³â¿¡´Â 417¾ï 9948¸¸ ´Þ·¯¿¡ À̸£·¶À¸¸ç, 2022³âºÎÅÍ 2031³â±îÁöÀÇ CAGRÀº 20.3%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¿ø°Ý ÀÇ·á¶õ Åë½Å ÀÎÇÁ¶ó¸¦ ÀÌ¿ëÇÏ¿© °Ë»ç³ª ÁøÂû µîÀÇ ÇコÄÉ¾î ¼­ºñ½º¸¦ ¿ø°ÝÀ¸·Î Á¦°øÇÔÀ¸·Î½á ÅÚ·¹Çコ³ª e-medicineÀ̶ó°íµµ ºÒ¸³´Ï´Ù. ¿ø°ÝÀÇ·á¶õ ÀüÀÚÁ¤º¸Åë½Å±â¼úÀ» ÀÌ¿ëÇÏ¿© ¿ø°ÝÁö¿¡¼­ ÀǷḦ Á¦°ø¡¤Áö¿øÇÔÀ¸·Î½á ÀÇ·á Á¾»çÀÚ °£ÀÇ °Å¸®°¡ ¶³¾îÁ® ÀÖ´Â °æ¿ì¿¡ ¹ß»ýÇÕ´Ï´Ù. µ¶¸³Àû ÀÎ ¼Ò±Ô¸ð ÀÇ·á ±â°ü¿¡¼­µµ Áö¿ª Ŭ¸®´Ð°ú °æÀïÇϰí ȯÀÚ¸¦ ³õÄ¡Áö ¾Êµµ·Ï ¿ø°Ý ÀǷḦ µµÀÔÇϱ⠽ÃÀÛÇß½À´Ï´Ù.

ÀÎÅÍ³Ý ½Ã´ëÀÇ µµ·¡´Â ¿ø°Ý Áø·áÀÇ ¹æ½Ä¿¡ Å« º¯È­¸¦ °¡Á®¿Ô´Ù. ½º¸¶Æ® µð¹ÙÀ̽ºÀÇ º¸±Þ°ú °íÈ­Áú ¿µ»óÀÇ Àü¼Û¿¡ ÀÇÇØ, ÇÁ¶óÀ̸Ӹ® Äɾî, ½ºÆä¼È¸®Æ¼ ÄɾîÀÇ ¾î´À ÂÊ¿¡¼­µµ, ´ë¸é Áø·á ´ë½Å, Áý, Á÷Àå, ¿ä¾ç¿ø µî¿¡ Àִ ȯÀÚ¿¡°Ô ¿ø°Ý ÀǷḦ Á¦°øÇÒ °¡´É¼ºÀÌ Å¾½À´Ï´Ù.

¿ø°ÝÁ¤½Å°ú ½ÃÀåÀÇ ¼ºÀåÀº Á¤½ÅÀå¾ÖÀÇ ¿ì·ÁÇÒ¸¸ÇÑ Áõ°¡, »ç¶÷µéÀÇ ºÒ¾È ¼öÁØÀÇ »ó½Â, °¡»ó Çコ ¼­ºñ½ºÀÇ ÀÌ¿ë Áõ°¡, ÇコÄÉ¾î ºÐ¾ßÀÇ ±â¼úÀÇ Áøº¸, ¿ø°Ý ÀÇ·á ¼Ö·ç¼ÇÀÇ Ã¤¿ë ±ÞÁõÀÌ ÁÖ¿ä ¿äÀΰú µÇ¾î ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇコÄÉ¾î ¾÷°è¿¡¼­ ȯÀÚÀÇ ¸®½ºÅ© °ü¸®¿¡ ÁÖ¸ñÀ» ¹Þ°í ÀÖÀ¸¸ç, ÀÓ»ó ¸®½ºÅ© ±×·ìÈ­¸¦ À§ÇÑ °í±Þ ¼Ö·ç¼ÇÀÇ Ã¤¿ëÀÌ Áõ°¡ÇÑ °Íµµ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

Åë½Å¸ÁÀÇ ¼ºÀå°ú Á¤ºÎÀÇ Áö¿øÀº ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ°í °æÀï¾÷üµé¿¡°Ô È®´ë ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 4¿ù, ¸¶À̵¶Àº Å×Å©³î·ÎÁö ÁÖµµÀÇ ÇコÄÉ¾î ±â¾÷ÀÎ ÆÛ½ºÆ® ¸Þµð½Å ÄÚÆÛ·¹À̼ǰú Á¦ÈÞÇØ, ¹Ì±¹¿¡¼­ ¿ø°Ý ÀÇ·á ¼Ö·ç¼Ç¿¡ÀÇ ¹«·á ¾×¼¼½º¸¦ 3°³¿ù°£ Á¦°øÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ Á¦ÈÞ¸¦ ÅëÇØ ȸ»ç´Â Áö¸®Àû ¾Æ¿ô¸®Ä¡¸¦ È®´ëÇÏ°í ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä Á¶»ç °á°ú
    • ÁÖ¿ä ÅõÀÚ Æ÷ÄÏ
  • Porter's Five Forces ºÐ¼®
  • ÁÖ¿ä ±â¾÷ÀÇ Æ÷Áö¼Å´×
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø ¿äÀÎ
    • ¾ïÁ¦ ¿äÀÎ
    • ±âȸ
  • COVID-19 ¿µÇ⠺м®

Á¦4Àå ¿ø°ÝÁ¤½Å°ú ½ÃÀå : Á¦Ç° À¯Çüº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • °¡Á¤³» ¼Ö·ç¼Ç
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • ¹ýÀÇÇÐ ¼Ö·ç¼Ç
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • ·çƾ ¼Ö·ç¼Ç
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • Å©¶óÀ̽ýº ¼Ö·ç¼Ç
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦5Àå ¿ø°ÝÁ¤½Å°ú ½ÃÀå : ¿¬·ÉÃþº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • ¼Ò¾Æ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • ¼ºÀÎ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ¼ºÀÎÀÇ Á¤½Å°ú ÅÚ·¾½Ã ½ÃÀå : ¼ºº°
      • ³²¼º ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
      • ¿©¼º ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
  • ³ëÀÎ ÀÇ·á
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦6Àå ¿ø°ÝÁ¤½Å°ú ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • Áö¿ª Á¤½Å °Ç°­ ¼¾ÅÍ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀΰú ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • Àü¹® Äɾî ȯ°æ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • ȨÄɾî
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • ±âŸ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦7Àå ¿ø°ÝÁ¤½Å°ú ½ÃÀå : Áö¿ªº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • ºÏ¹Ì
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð ÃßÀÌ¡¤¿¹Ãø : Á¦Ç° À¯Çüº°
    • ºÏ¹ÌÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿¬·ÉÃþº°
      • ºÏ¹Ì ¼ºÀÎ¿ë ¿ø°Ý Á¤½Å ÀÇÇÐ ½ÃÀå : ¼ºº°
    • ºÏ¹ÌÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿£µåÀ¯Àúº°
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
  • À¯·´
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • À¯·´ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Á¦Ç° À¯Çüº°
    • À¯·´ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿¬·ÉÃþº°
      • À¯·´ÀÇ ¼ºÀοë Á¤½Å°ú ÀÇ·á ½ÃÀå : ¼ºº°
    • À¯·´ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°
    • À¯·´ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ¿µ±¹
      • ÀÌÅ»¸®¾Æ
      • ½ºÆäÀÎ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Á¦Ç° À¯Çüº°
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿¬·ÉÃþº°
      • ¾Æ½Ã¾ÆÅÂÆò¾ç ¼ºÀÎ¿ë ¿ø°Ý Á¤½Å ÀÇÇÐ ½ÃÀå : ¼ºº°
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ÀϺ»
      • Áß±¹
      • È£ÁÖ
      • Àεµ
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • LAMEA
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Á¦Ç° À¯Çüº°
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿¬·ÉÃþº°
      • LAMEA ¼ºÀÎ¿ë ¿ø°Ý Á¤½Å ÀÇÇÐ ½ÃÀå : ¼ºº°
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿£µåÀ¯Àúº°
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ºê¶óÁú
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ³²¾ÆÇÁ¸®Ä« °øÈ­±¹
      • ±âŸ LAMEA

Á¦8Àå ±â¾÷ Á¤¼¼

  • ¼Ò°³
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÁÖ¿ä 10°³»çÀÇ Á¦Ç° ¸ÅÇÎ
  • °æÀï ´ë½Ãº¸µå
  • °æÇÕÀÇ È÷Æ® ¸Ê
  • ÁÖ¿ä ¹ßÀü

Á¦9Àå ±â¾÷ ÇÁ·ÎÇÊ

  • Koninklijke Philips NV
  • Medtronic
  • GE Healthcare
  • Cerner Corporation
  • Siemens Healthineers
  • Cisco Systems, Inc
  • Teladoc Health Inc
  • American Well
  • AMC Health
  • MDLive
ksm 23.03.27

The global telepsychiatry market was valued at $6,531.0 million in 2021, and is projected to reach $41,799.48 million by 2031, registering a CAGR of 20.3% from 2022 to 2031.

Telemedicine, also referred to as telehealth or e-medicine, is the remote delivery of healthcare services, including exams and consultations, over the telecommunications infrastructure. Telemedicine is the use of electronic information to communications technologies to provide and support healthcare when distance separates the participants. Even smaller, independent medical practice providers are starting to embrace telemedicine to compete with local retail clinics and stop losing their patients.

The rise of the internet age brought with it profound changes to the practice of telemedicine. The proliferation of smart devices and the ability of high-quality video transmission opened up the possibility of delivering remote healthcare to patients in their homes, workplaces, or assisted living facilities as an alternative to in-person visits for both primary and specialty care.

The growth of the telepsychiatry market is majorly driven by an alarming increase in the prevalence of mental disorders, growing anxiety levels in people, a rise in use of virtual health services, advancements in technologies of the healthcare sector, and a surge in the adoption of telehealth solutions. In addition, the increase in the focus of the healthcare industry on patient risk management and rise in adoption of advanced solutions for clinical risk grouping boosts the growth of the market.

Growing telecommunication networks along with government support will augment the market growth, offering expansion opportunities for market competitors. For instance, in April 2020, MyDoc partnered with First Medicine Corporation, a technology-driven healthcare company, to provide free access to the telemedicine solution in the U.S. for 3 months. This partnership will enable the company to expand its geographic outreach and strengthen its market positioning.

The telepsychiatry market is segmented on the basis of product, age group, end user, and region. As per product, the market is classified into in-home solutions, forensic solutions, routine solutions, and crisis solutions. Depending on age group, it is divided into adult, pediatric & adolescent, and geriatric. According to end user, it is categorized into community mental health centers, specialty care settings, and other. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Acadia Healthcare, Ascension, Behavioral Health Services Incorporated, Bright Harbor Healthcare, Centene Corporation, Elevance Health, Oracle Corporation, Pyramid Healthcare, Inc., Strategic Behavioral Health, LLC, and Welligent Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the telepsychiatry market analysis from 2021 to 2031 to identify the prevailing telepsychiatry market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the telepsychiatry market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global telepsychiatry market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • In-home solutions
  • Forensic solutions
  • Routine solutions
  • Crisis solutions

By Age group

  • Pediatric
  • Adult
    • Gender
    • Male
    • Female
  • Geriatric

By End User

  • Community Mental Health Centers
  • Specialty Care Settings
  • Homecare
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Koninklijke Philips N.V.
    • Medtronic
    • GE Healthcare
    • Cerner Corporation
    • Siemens Healthineers
    • Cisco Systems, Inc
    • Teladoc Health Inc
    • American Well
    • AMC Health
    • MDLive

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: TELEPSYCHIATRY MARKET, BY PRODUCT TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 In-home solutions
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Forensic solutions
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Routine solutions
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Crisis solutions
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country

CHAPTER 5: TELEPSYCHIATRY MARKET, BY AGE GROUP

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Pediatric
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Adult
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
    • 5.3.4 Adult Telepsychiatry Market by Gender
      • 5.3.4.1 Male Market size and forecast, by region
      • 5.3.4.2 Female Market size and forecast, by region
  • 5.4 Geriatric
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: TELEPSYCHIATRY MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Community Mental Health Centers
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Specialty Care Settings
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Homecare
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country
  • 6.5 Others
    • 6.5.1 Key market trends, growth factors and opportunities
    • 6.5.2 Market size and forecast, by region
    • 6.5.3 Market analysis by country

CHAPTER 7: TELEPSYCHIATRY MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product Type
    • 7.2.3 North America Market size and forecast, by Age group
      • 7.2.3.1 North America Adult Telepsychiatry Market by Gender
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Product Type
      • 7.2.5.1.2 Market size and forecast, by Age group
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Product Type
      • 7.2.5.2.2 Market size and forecast, by Age group
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Product Type
      • 7.2.5.3.2 Market size and forecast, by Age group
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product Type
    • 7.3.3 Europe Market size and forecast, by Age group
      • 7.3.3.1 Europe Adult Telepsychiatry Market by Gender
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Product Type
      • 7.3.5.1.2 Market size and forecast, by Age group
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Product Type
      • 7.3.5.2.2 Market size and forecast, by Age group
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Product Type
      • 7.3.5.3.2 Market size and forecast, by Age group
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Product Type
      • 7.3.5.4.2 Market size and forecast, by Age group
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Product Type
      • 7.3.5.5.2 Market size and forecast, by Age group
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Product Type
      • 7.3.5.6.2 Market size and forecast, by Age group
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Age group
      • 7.4.3.1 Asia-Pacific Adult Telepsychiatry Market by Gender
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Product Type
      • 7.4.5.1.2 Market size and forecast, by Age group
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Product Type
      • 7.4.5.2.2 Market size and forecast, by Age group
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Market size and forecast, by Product Type
      • 7.4.5.3.2 Market size and forecast, by Age group
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Market size and forecast, by Product Type
      • 7.4.5.4.2 Market size and forecast, by Age group
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Market size and forecast, by Product Type
      • 7.4.5.5.2 Market size and forecast, by Age group
      • 7.4.5.5.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product Type
    • 7.5.3 LAMEA Market size and forecast, by Age group
      • 7.5.3.1 LAMEA Adult Telepsychiatry Market by Gender
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Product Type
      • 7.5.5.1.2 Market size and forecast, by Age group
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Product Type
      • 7.5.5.2.2 Market size and forecast, by Age group
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Product Type
      • 7.5.5.3.2 Market size and forecast, by Age group
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Product Type
      • 7.5.5.4.2 Market size and forecast, by Age group
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Koninklijke Philips N.V.
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Medtronic
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 GE Healthcare
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Cerner Corporation
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Siemens Healthineers
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Cisco Systems, Inc
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Teladoc Health Inc
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 American Well
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 AMC Health
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 MDLive
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦